AI-generated summary
The authors reviewed eight randomized controlled trials with 242 organ transplant recipients evaluating nonsystemic treatments for actinic keratosis. Methyl aminolaevulinate photodynamic therapy showed the highest complete clearance rates, and the authors report that the overall risk of bias was high and the evidence limited.
- Participants
- 242
- Studies included
- 8
- Who or what was studied
- Organ transplant recipients with actinic keratosis
- Limits stated in the abstract
- The authors state that overall risk of bias was high and that limited evidence is available.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on academic.oup.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Systematic review, Risk of bias, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.